ATE448245T1 - Piroplasmid-impfstoff - Google Patents
Piroplasmid-impfstoffInfo
- Publication number
- ATE448245T1 ATE448245T1 AT04787138T AT04787138T ATE448245T1 AT E448245 T1 ATE448245 T1 AT E448245T1 AT 04787138 T AT04787138 T AT 04787138T AT 04787138 T AT04787138 T AT 04787138T AT E448245 T1 ATE448245 T1 AT E448245T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- piroplasmid
- relates
- immunogenic fragment
- vaccine
- Prior art date
Links
- 241000223834 Piroplasmida Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 6
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 230000002163 immunogen Effects 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03020898 | 2003-09-14 | ||
| PCT/EP2004/052169 WO2005026199A2 (en) | 2003-09-14 | 2004-09-14 | Piroplasmid vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE448245T1 true ATE448245T1 (de) | 2009-11-15 |
Family
ID=34306771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04787138T ATE448245T1 (de) | 2003-09-14 | 2004-09-14 | Piroplasmid-impfstoff |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7465459B2 (de) |
| EP (1) | EP1664097B1 (de) |
| JP (1) | JP2007527707A (de) |
| AT (1) | ATE448245T1 (de) |
| AU (1) | AU2004272312B2 (de) |
| BR (1) | BRPI0414353A (de) |
| CA (1) | CA2536652A1 (de) |
| DE (1) | DE602004024085D1 (de) |
| DK (1) | DK1664097T3 (de) |
| ES (1) | ES2335891T3 (de) |
| PL (1) | PL1664097T3 (de) |
| PT (1) | PT1664097E (de) |
| WO (1) | WO2005026199A2 (de) |
| ZA (1) | ZA200602107B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120039926A1 (en) * | 2009-04-14 | 2012-02-16 | Cel-Sci Corporation | Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells |
| BRPI1003750A2 (pt) | 2010-07-22 | 2012-04-10 | Univ Sao Paulo | microrganismos recombinantes, métodos de preparação de linhagens vacinais, antìgenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia |
| CN105524935B (zh) * | 2016-01-07 | 2018-11-06 | 华中农业大学 | 东方巴贝斯虫凝血酶素基因1及其编码的蛋白 |
| WO2020174690A1 (ja) * | 2019-02-25 | 2020-09-03 | Kaico株式会社 | バベシア原虫の表面抗原タンパク質、バベシア原虫に対する抗体の検出方法、バベシア症の診断方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA902546B (en) * | 1989-04-04 | 1991-04-24 | Univ Florida | Novel proteins and cloned genes for diagnosis and prophylaxis of babesiosis |
| US5198535A (en) * | 1991-01-10 | 1993-03-30 | The United States Of America As Represented By The Secretary Of The Navy | Protective malaria sporozoite surface protein immunogen and gene |
| US6902926B1 (en) * | 2000-11-09 | 2005-06-07 | University Of Vermont And State Agricultural College | Toxoplasma gondii apical membrane antigen-1 |
-
2004
- 2004-09-14 DE DE602004024085T patent/DE602004024085D1/de not_active Expired - Lifetime
- 2004-09-14 US US10/571,667 patent/US7465459B2/en not_active Expired - Fee Related
- 2004-09-14 AT AT04787138T patent/ATE448245T1/de active
- 2004-09-14 JP JP2006525840A patent/JP2007527707A/ja active Pending
- 2004-09-14 ES ES04787138T patent/ES2335891T3/es not_active Expired - Lifetime
- 2004-09-14 PL PL04787138T patent/PL1664097T3/pl unknown
- 2004-09-14 PT PT04787138T patent/PT1664097E/pt unknown
- 2004-09-14 CA CA002536652A patent/CA2536652A1/en not_active Abandoned
- 2004-09-14 BR BRPI0414353-1A patent/BRPI0414353A/pt not_active IP Right Cessation
- 2004-09-14 AU AU2004272312A patent/AU2004272312B2/en not_active Ceased
- 2004-09-14 DK DK04787138.9T patent/DK1664097T3/da active
- 2004-09-14 EP EP04787138A patent/EP1664097B1/de not_active Expired - Lifetime
- 2004-09-14 WO PCT/EP2004/052169 patent/WO2005026199A2/en not_active Ceased
-
2006
- 2006-03-13 ZA ZA200602107A patent/ZA200602107B/xx unknown
-
2008
- 2008-11-21 US US12/275,404 patent/US7799330B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2536652A1 (en) | 2005-03-24 |
| WO2005026199A2 (en) | 2005-03-24 |
| ZA200602107B (en) | 2008-11-26 |
| DE602004024085D1 (de) | 2009-12-24 |
| EP1664097A2 (de) | 2006-06-07 |
| AU2004272312A1 (en) | 2005-03-24 |
| PL1664097T3 (pl) | 2010-05-31 |
| WO2005026199A3 (en) | 2005-09-15 |
| US7465459B2 (en) | 2008-12-16 |
| JP2007527707A (ja) | 2007-10-04 |
| US7799330B2 (en) | 2010-09-21 |
| DK1664097T3 (da) | 2010-03-29 |
| BRPI0414353A (pt) | 2006-11-14 |
| US20090191236A1 (en) | 2009-07-30 |
| ES2335891T3 (es) | 2010-04-06 |
| EP1664097B1 (de) | 2009-11-11 |
| AU2004272312B2 (en) | 2010-12-09 |
| US20070253974A1 (en) | 2007-11-01 |
| PT1664097E (pt) | 2010-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL404537A1 (pl) | Wirusy stowarzyszone z adenowirusem, kompozycje, wyizolowane bialko kapsydu, wyizolowana lub syntetyczna czasteczka kwasu nukleinowego, sposób wytwarzania rekombinowanych wirusów, komórki gospodarza, bialka obejmujace fragment bialka kapsydu AAV, sztuczne bialka, rekombinowane wirusy, czasteczki, sposoby dostarczania transgenu do komórki, sposób identyfikacji serotypu sekwencji wirusa (AAV), zestaw diagnostyczny, sposób izolacji nowych wirusów, nowe serotypy wirusa, wyizolowane wirusy, rekombinowana komórka, zastosowanie wirusa | |
| DK1586646T3 (da) | Lawsonia intracellularis-vaccine | |
| BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| WO2005081716A3 (en) | DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) | |
| ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
| WO2003095480A3 (en) | Brachyspira hyodysenteriae vaccine | |
| ATE448245T1 (de) | Piroplasmid-impfstoff | |
| NO20081541L (no) | Ny sjo-lus vaksine | |
| WO2004007726A3 (en) | Brachyspira hyodysenteriae vaccine | |
| WO2004024769A3 (en) | Ostertagia vaccine | |
| ATE450546T1 (de) | Impfstoffe mit ornithobakterium rhinotracheale- untereinheit | |
| AR040830A1 (es) | Vacuna para combatir la infeccion que produce la mastitis | |
| ATE251215T1 (de) | Helicobacter felis impfstoff | |
| TH62170A (th) | วัคซีนเชื้อก่อโรค Lawsonia intracellularis | |
| TH88495B (th) | วัคซีนชนิดใหม่สำหรับปรสิตทางทะเล | |
| WO2004013281A3 (en) | Novel proteins and their uses | |
| WO2004044126A3 (en) | Novel proteins and their uses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1664097 Country of ref document: EP |